Arad, Israel

Elina Aizenshtein

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elina Aizenshtein: Innovator in Protein Modification

Introduction: Elina Aizenshtein, an accomplished inventor based in Arad, Israel, has made significant contributions to the field of biochemistry through her innovative work in protein modification. With a focus on enhancing the efficacy and safety of vaccines, her research has garnered recognition and has led to a patent that showcases her expertise and dedication to scientific advancement.

Latest Patents: Aizenshtein holds a patent for "Proteins modified with (amino) monosaccharide-biotin adduct." This innovative concept involves the coating of proteins, such as antibodies, with non-immunogenic molecules, selected from amino-monosaccharide-biotin adducts or monosaccharide-biotin adducts. The result is a coated protein that exhibits diminished immunogenicity relative to the uncoated variant while maintaining its biological activity. This groundbreaking approach has the potential to facilitate cross-species vaccination, making substantial impacts in the field of immunology.

Career Highlights: Elina Aizenshtein's career is marked by her relentless pursuit of innovation in biochemistry. Currently affiliated with Gavish-Galilee Bio Applications Ltd., she collaborates with leading minds in the industry to push the boundaries of what is possible in protein engineering and vaccine development. Her patent not only advances scientific knowledge but also opens new avenues for research and application in immunotherapy.

Collaborations: Throughout her career, Elina has worked alongside esteemed colleagues, including Jacob Pitcovski and Jacob Vaya. Their collective expertise and innovative ideas have fostered a collaborative environment that promotes the advancement of cutting-edge technologies in biological applications. The synergy created within their team has led to significant breakthroughs, particularly in the realm of therapeutic proteins.

Conclusion: Elina Aizenshtein's contributions to the field of protein modification highlight her as a notable inventor and innovator. Her patent underscores her commitment to enhancing vaccine development and safety. As she continues her work at Gavish-Galilee Bio Applications Ltd., Elina Aizenshtein remains a vital figure in the quest for advanced solutions in biochemistry, paving the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…